vs
弗雷斯特研究公司（FORR）与GLAUKOS Corp（GKOS）财务数据对比。点击上方公司名可切换其他公司
GLAUKOS Corp的季度营收约是弗雷斯特研究公司的1.5倍（$150.6M vs $101.1M），GLAUKOS Corp净利率更高（6.2% vs -33.5%，领先39.7%），GLAUKOS Corp同比增速更快（41.2% vs -6.5%），过去两年GLAUKOS Corp的营收复合增速更高（25.4% vs 0.5%）
福雷斯特研究公司是一家全球领先的研究咨询机构，主营业务涵盖行业研究、管理咨询与行业峰会举办，客户群体包括全球大型企业、科技公司与消费领域领军企业，公司总部位于美国马萨诸塞州剑桥市。
Glaukos Corp是一家专注于眼科领域的医疗科技企业，开发并商业化用于治疗青光眼、角膜疾病等眼部病症的微创手术器械、处方药物及消费级产品，主要市场覆盖北美、欧洲及亚太地区，为全球医院、眼科诊所及患者提供服务。
FORR vs GKOS — 直观对比
营收规模更大
GKOS
是对方的1.5倍
$101.1M
营收增速更快
GKOS
高出47.6%
-6.5%
净利率更高
GKOS
高出39.7%
-33.5%
两年增速更快
GKOS
近两年复合增速
0.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $101.1M | $150.6M |
| 净利润 | $-33.9M | $9.4M |
| 毛利率 | 56.7% | 77.9% |
| 营业利润率 | -36.6% | 9.0% |
| 净利率 | -33.5% | 6.2% |
| 营收同比 | -6.5% | 41.2% |
| 净利润同比 | -7941.4% | — |
| 每股收益（稀释后） | $-1.75 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FORRGKOS
| Q1 26 | — | $150.6M | ||
| Q4 25 | $101.1M | $143.1M | ||
| Q3 25 | $94.3M | $133.5M | ||
| Q2 25 | $111.7M | $124.1M | ||
| Q1 25 | $89.9M | $106.7M | ||
| Q4 24 | $108.0M | $105.5M | ||
| Q3 24 | $102.5M | $96.7M | ||
| Q2 24 | $121.8M | $95.7M |
净利润FORRGKOS
| Q1 26 | — | $9.4M | ||
| Q4 25 | $-33.9M | $-133.7M | ||
| Q3 25 | $-2.1M | $-16.2M | ||
| Q2 25 | $3.9M | $-19.7M | ||
| Q1 25 | $-87.3M | $-18.1M | ||
| Q4 24 | $432.0K | $-33.6M | ||
| Q3 24 | $-5.8M | $-21.4M | ||
| Q2 24 | $6.3M | $-50.5M |
毛利率FORRGKOS
| Q1 26 | — | 77.9% | ||
| Q4 25 | 56.7% | -1.1% | ||
| Q3 25 | 60.0% | 78.4% | ||
| Q2 25 | 55.5% | 78.3% | ||
| Q1 25 | 55.9% | 77.2% | ||
| Q4 24 | 58.8% | 72.9% | ||
| Q3 24 | 60.5% | 76.6% | ||
| Q2 24 | 57.3% | 76.4% |
营业利润率FORRGKOS
| Q1 26 | — | 9.0% | ||
| Q4 25 | -36.6% | -97.7% | ||
| Q3 25 | 4.7% | -12.3% | ||
| Q2 25 | 6.2% | -18.3% | ||
| Q1 25 | -97.5% | -19.4% | ||
| Q4 24 | -0.5% | -27.2% | ||
| Q3 24 | -0.7% | -25.5% | ||
| Q2 24 | 9.3% | -31.3% |
净利率FORRGKOS
| Q1 26 | — | 6.2% | ||
| Q4 25 | -33.5% | -93.4% | ||
| Q3 25 | -2.3% | -12.2% | ||
| Q2 25 | 3.5% | -15.8% | ||
| Q1 25 | -97.1% | -17.0% | ||
| Q4 24 | 0.4% | -31.8% | ||
| Q3 24 | -5.7% | -22.1% | ||
| Q2 24 | 5.2% | -52.8% |
每股收益（稀释后）FORRGKOS
| Q1 26 | — | — | ||
| Q4 25 | $-1.75 | $-2.34 | ||
| Q3 25 | $-0.11 | $-0.28 | ||
| Q2 25 | $0.20 | $-0.34 | ||
| Q1 25 | $-4.62 | $-0.32 | ||
| Q4 24 | $0.02 | $-0.56 | ||
| Q3 24 | $-0.30 | $-0.39 | ||
| Q2 24 | $0.33 | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.3M | $276.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $126.5M | $670.9M |
| 总资产 | $404.0M | $893.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FORRGKOS
| Q1 26 | — | $276.7M | ||
| Q4 25 | $63.3M | $90.8M | ||
| Q3 25 | $65.1M | $98.2M | ||
| Q2 25 | $67.8M | $100.8M | ||
| Q1 25 | $75.6M | $114.3M | ||
| Q4 24 | $56.1M | $169.6M | ||
| Q3 24 | $62.8M | $100.1M | ||
| Q2 24 | $58.9M | $68.1M |
股东权益FORRGKOS
| Q1 26 | — | $670.9M | ||
| Q4 25 | $126.5M | $656.2M | ||
| Q3 25 | $157.7M | $769.5M | ||
| Q2 25 | $159.5M | $765.1M | ||
| Q1 25 | $147.4M | $764.0M | ||
| Q4 24 | $229.5M | $766.9M | ||
| Q3 24 | $234.3M | $668.5M | ||
| Q2 24 | $237.1M | $665.2M |
总资产FORRGKOS
| Q1 26 | — | $893.3M | ||
| Q4 25 | $404.0M | $893.5M | ||
| Q3 25 | $414.2M | $999.4M | ||
| Q2 25 | $436.0M | $987.0M | ||
| Q1 25 | $439.8M | $966.2M | ||
| Q4 24 | $503.9M | $974.8M | ||
| Q3 24 | $505.3M | $926.5M | ||
| Q2 24 | $524.2M | $919.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.2M | — |
| 自由现金流经营现金流 - 资本支出 | $-4.3M | — |
| 自由现金流率自由现金流/营收 | -4.2% | — |
| 资本支出强度资本支出/营收 | 1.1% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $18.1M | — |
8季度趋势，按日历期对齐
经营现金流FORRGKOS
| Q1 26 | — | — | ||
| Q4 25 | $-3.2M | $6.8M | ||
| Q3 25 | $1.2M | $-10.1M | ||
| Q2 25 | $-3.6M | $7.0M | ||
| Q1 25 | $26.7M | $-18.5M | ||
| Q4 24 | $-1.8M | $507.0K | ||
| Q3 24 | $264.0K | $-9.6M | ||
| Q2 24 | $-2.9M | $-18.4M |
自由现金流FORRGKOS
| Q1 26 | — | — | ||
| Q4 25 | $-4.3M | $3.9M | ||
| Q3 25 | $524.0K | $-11.7M | ||
| Q2 25 | $-4.2M | $5.8M | ||
| Q1 25 | $26.1M | $-20.5M | ||
| Q4 24 | $-2.5M | $-1.2M | ||
| Q3 24 | $-223.0K | $-11.0M | ||
| Q2 24 | $-3.7M | $-20.5M |
自由现金流率FORRGKOS
| Q1 26 | — | — | ||
| Q4 25 | -4.2% | 2.7% | ||
| Q3 25 | 0.6% | -8.8% | ||
| Q2 25 | -3.8% | 4.7% | ||
| Q1 25 | 29.0% | -19.2% | ||
| Q4 24 | -2.3% | -1.2% | ||
| Q3 24 | -0.2% | -11.4% | ||
| Q2 24 | -3.1% | -21.4% |
资本支出强度FORRGKOS
| Q1 26 | — | — | ||
| Q4 25 | 1.1% | 2.0% | ||
| Q3 25 | 0.7% | 1.2% | ||
| Q2 25 | 0.5% | 0.9% | ||
| Q1 25 | 0.7% | 1.8% | ||
| Q4 24 | 0.6% | 1.6% | ||
| Q3 24 | 0.5% | 1.5% | ||
| Q2 24 | 0.7% | 2.2% |
现金转化率FORRGKOS
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.93× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -4.24× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.46× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FORR
| Research Segment | $82.2M | 81% |
| Consulting Segment | $16.2M | 16% |
| Billable Expenses | $1.5M | 2% |
| Professional Services | $1.4M | 1% |
GKOS
暂无分部数据
